You are here

Article Text

Article menu
Download PDFPDF
Letter
Complication rates of ablation therapies for hepatocellular carcinoma: a difficult comparison with an easy solution
  1. V Arienti,
  2. S Pretolani
  1. Centro di Ricerca e Formazione in Ecografia Internistica, Internistica e Vascolare, Dipartimento Medico, Ospedale Maggiore, Bologna, Italy
  1. Correspondence to:
    Dr V Arienti
    Centro di Ricerca e Formazione in Ecografia Internistica, Internistica e Vascolare, Dipartimento Medico, Ospedale Maggiore, Bologna 40133, Italy; vincenzo.arienti{at}unibo.it

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read the recent debate from Taipei (Gut 2005;54:1151–6) on which is the best image guided ablation therapy for hepatocellular carcinoma (HCC), proposed by Lin and colleagues1 and Huo and colleagues.2 This is an interesting topic for hepatologists and gastroenterologists.

    The papers by Lin et al stated that in the treatment of HCC, radiofrequency (RFA) was superior to percutaneous ethanol injection (PEI) and percutaneous acetic acid injection (PAI) with respect to local recurrence, overall survival, and cancer free survival, but RFA also caused more major complications. In contrast, Huo et al stressed that …

    View Full Text

    Footnotes

    • Conflict of interest: None declared.

    Linked Articles